ENTITY

Checkpoint Therapeutics (CKPT US)

12
Analysis
Health Care • United States
Checkpoint Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on the acquisition, development, and commercialization of immune-enhanced combination treatments for patients with solid tumor cancers. Checkpoint Therapeutics serves patients in the United States.
more
Exchange Announcement • 30 May 2025 22:07

Current Report (Form 8-K | Period ending 2025-05-30)

Exchange Announcement • 29 May 2025 19:00

Current Report (Form 8-K | Period ending 2025-05-28)

Exchange Announcement • 22 May 2025 20:00

Current Report (Form 8-K | Period ending 2025-05-19)

Exchange Announcement • 14 May 2025 04:35

Current Report (Form 8-K | Period ending 2025-05-13)

Exchange Announcement • 13 May 2025 08:00

Quarterly Report (Form 10-Q | Period ending 2025-03-31)

x